Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Systematic Analyses Reveals the Functional Roles of Ferroptosis Across Cancers
34 Pages Posted: 9 Feb 2020
More...Abstract
Background: Ferroptosis is a newly discovered type of cell death that is closely related to cancer, however, the characteristics of ferroptosis and its regulators in cancers are still largely unknown.
Methods: Based on the cancer omics data in The Cancer Genome Atlas, we comprehensively analyzed the alterations of ferroptosis regulator genes (FRGs) and computationally established the ferroptosis potential index (FPI) to reveal the functional roles of ferroptosis in cancer.
Findings: We found that the mutation rates of FRGs were generally low, but most FRGs were differentially expressed in tumors among various cancer types. Frequent copy number alterations (CNA) and differential DNA methylation of FRGs contributed greatly to their aberrant expression. In most cancers, the FPI was higher in tumors than in the adjacent normal tissues and was associated with histological/molecular subtypes and clinical features. We observed that the FPI was negatively correlated with a number of metabolism pathways such as terpenoid backbone biosynthesis, but positively associated with metastasis-related pathways such as epithelial-mesenchymal transition (EMT), WNT beta-catenin signaling and angiogenesis. The FPI was also correlated immune microenvironment since it was positively correlated with pathways such as IL6 JAK-STAT signaling, inflammatory response, complement. Furthermore, it was observed that high FPI predicted significantly worse overall survival in glioblastoma multiforme, renal clear/papillary cell carcinoma, hepatocellular carcinoma, and lung adenocarcinoma, while FPI and FRGs were intensively correlated with cancer drug sensitivity.
Interpretation: Our study presents a systematical analysis of ferroptosis and its regulatory genes across cancers, and highlights the potential of ferroptosis-based cancer therapy.
Funding Statement: This work was supported by grants from National Key R&D Program of China (2018YFC1313300 to RH.X.), Program for Guangdong Introducing Innovative and Entrepreneurial Teams (2017ZT07S096 to ZX.L.), the Natural Science Foundation of China (81972239 and 91953123 to ZX.L.), Pearl River S&T Nova Program of Guangzhou (201906010088 to ZX.L.), CAMS Innovation Fund for Medical Sciences (2019-I2M-5-036 to RH.X.), Natural Science Foundation of Guangdong Province (2017A030313485 to RH.X., 2019A1515010634 to ZX.L.); and Science and Technology Program of Guangdong (2019B020227002 to RH.X.).
Declaration of Interests: The authors declare that they have no competing interests.
Ethics Approval Statement: Not required.
Keywords: ferroptosis; pan-cancer analysis; phenotype; Survival; drug sensitivity
Suggested Citation: Suggested Citation